Parex­el re­cruits top FDA on­col­o­gy ex­pert Amy Mc­K­ee for new R&D ini­tia­tive

Amy Mc­K­ee, one of Richard Paz­dur’s close al­lies in build­ing out the On­col­o­gy Cen­ter of Ex­cel­lence at the FDA, has left the agency to help com­pa­nies nav­i­gate a reg­u­la­to­ry land­scape she helped shape.

As VP of reg­u­la­to­ry con­sult­ing ser­vices at Parex­el, she joins a nascent on­col­o­gy ini­tia­tive ded­i­cat­ed to con­nect­ing dif­fer­ent busi­ness units to work up de­vel­op­ment plans — not un­like how she cre­at­ed a com­mu­ni­ca­tions struc­ture for dif­fer­ent of­fices across the FDA’s cen­ters for drug, bi­o­log­ics and de­vices.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER